JP2017525752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525752A5 JP2017525752A5 JP2017515008A JP2017515008A JP2017525752A5 JP 2017525752 A5 JP2017525752 A5 JP 2017525752A5 JP 2017515008 A JP2017515008 A JP 2017515008A JP 2017515008 A JP2017515008 A JP 2017515008A JP 2017525752 A5 JP2017525752 A5 JP 2017525752A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- substantially pure
- acid seq
- protein
- homology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims 100
- 108090000623 proteins and genes Proteins 0.000 claims 100
- 150000001413 amino acids Chemical class 0.000 claims 65
- 239000000047 product Substances 0.000 claims 26
- 230000000694 effects Effects 0.000 claims 21
- 108060003951 Immunoglobulin Proteins 0.000 claims 15
- 102000018358 immunoglobulin Human genes 0.000 claims 15
- 239000000706 filtrate Substances 0.000 claims 14
- 238000001990 intravenous administration Methods 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000002031 ethanolic fraction Substances 0.000 claims 4
- 238000001914 filtration Methods 0.000 claims 4
- 239000012467 final product Substances 0.000 claims 3
- 229940036107 hepatitis b immunoglobulin Drugs 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000007865 diluting Methods 0.000 claims 2
- 238000001728 nano-filtration Methods 0.000 claims 2
- 238000000108 ultra-filtration Methods 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462003664P | 2014-05-28 | 2014-05-28 | |
| US62/003,664 | 2014-05-28 | ||
| PCT/US2015/032807 WO2015184050A1 (en) | 2014-05-28 | 2015-05-28 | Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017525752A JP2017525752A (ja) | 2017-09-07 |
| JP2017525752A5 true JP2017525752A5 (enExample) | 2018-05-17 |
Family
ID=54699755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017515008A Pending JP2017525752A (ja) | 2014-05-28 | 2015-05-28 | 静注用免疫グロブリンの精製組成物及びリンパ球を調整しｂ型肝炎を治療するためのｋｈタンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3148574B1 (enExample) |
| JP (1) | JP2017525752A (enExample) |
| CN (1) | CN107106664A (enExample) |
| AU (1) | AU2015266997A1 (enExample) |
| BR (1) | BR112016027818A2 (enExample) |
| CA (1) | CA2949994A1 (enExample) |
| ES (1) | ES2878043T3 (enExample) |
| MX (1) | MX2016015574A (enExample) |
| RU (1) | RU2016151761A (enExample) |
| WO (1) | WO2015184050A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017525752A (ja) | 2014-05-28 | 2017-09-07 | レア アンチボディ アンチジェン サプライ インク | 静注用免疫グロブリンの精製組成物及びリンパ球を調整しｂ型肝炎を治療するためのｋｈタンパク質 |
| US20160289300A1 (en) * | 2015-04-02 | 2016-10-06 | Kieu Hoang | Method of manufacturing intravenous immunoglobulin from fraction iii |
| CN107921080A (zh) * | 2015-04-02 | 2018-04-17 | K·黄 | 由组分iii制造并纯化出用于静脉注射的凝血酶原复合物浓缩剂的方法以及治疗和预防具有抑制剂的a型血友病或感染了hiv‑1和hiv‑2的b型血友病患者的方法 |
| CN118903378A (zh) * | 2024-03-19 | 2024-11-08 | 北京达尔文细胞生物科技有限公司 | 一种蛋白聚合物在治疗渐冻症中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3825429C2 (de) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| GB0315248D0 (en) * | 2003-06-30 | 2003-08-06 | Hoffmann La Roche | HCV regulated protein expression |
| TWI489994B (zh) * | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
| CA2639003A1 (en) * | 2008-08-20 | 2010-02-20 | Canadian Blood Services | Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations |
| KR20130070576A (ko) * | 2010-04-09 | 2013-06-27 | 노보자임스 바이오파마 디케이 에이/에스 | 알부민 유도체 및 변이체 |
| TR201904224T4 (tr) * | 2010-05-14 | 2019-05-21 | Univ Colorado Regents | Geliştirilmiş kompleman reseptör 2 (CR2) hedefleme grupları. |
| TW201335181A (zh) | 2012-01-31 | 2013-09-01 | Kieu Hoang | ５５種新發現的蛋白質之序列及其應用 |
| JP2017525752A (ja) | 2014-05-28 | 2017-09-07 | レア アンチボディ アンチジェン サプライ インク | 静注用免疫グロブリンの精製組成物及びリンパ球を調整しｂ型肝炎を治療するためのｋｈタンパク質 |
-
2015
- 2015-05-28 JP JP2017515008A patent/JP2017525752A/ja active Pending
- 2015-05-28 MX MX2016015574A patent/MX2016015574A/es unknown
- 2015-05-28 RU RU2016151761A patent/RU2016151761A/ru not_active Application Discontinuation
- 2015-05-28 CA CA2949994A patent/CA2949994A1/en active Pending
- 2015-05-28 ES ES15799654T patent/ES2878043T3/es active Active
- 2015-05-28 BR BR112016027818A patent/BR112016027818A2/pt not_active Application Discontinuation
- 2015-05-28 AU AU2015266997A patent/AU2015266997A1/en not_active Abandoned
- 2015-05-28 CN CN201580041532.2A patent/CN107106664A/zh active Pending
- 2015-05-28 EP EP15799654.7A patent/EP3148574B1/en not_active Revoked
- 2015-05-28 WO PCT/US2015/032807 patent/WO2015184050A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR121861A2 (es) | MÉTODO PARA PREPARAR UNA COMPOSICIÓN DE IgG ENRIQUECIDA A PARTIR DE PLASMA | |
| CN102124027B (zh) | 产生富含分泌型免疫球蛋白的乳组分的方法 | |
| JP2017525752A5 (enExample) | ||
| TWI643865B (zh) | 抗體純化方法 | |
| WO2014160463A8 (en) | Prefusion rsv f proteins and their use | |
| RU2015151869A (ru) | Способ непрерывной многостадийной очистки антител | |
| JP2012528190A5 (enExample) | ||
| FI4104859T3 (fi) | Menetelmä vasta-aineiden ja niiden terapeuttisten tuotteiden väkevöimiseksi | |
| JP2016519137A5 (enExample) | ||
| JP2014506790A5 (enExample) | ||
| WO2017143298A8 (en) | Functional mung bean-derived compositions | |
| JP2015509506A5 (enExample) | ||
| Melero et al. | The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals | |
| MX2013006611A (es) | Tratamiento de formaciones iliticas al usar un agente quelante. | |
| JP2013528183A5 (enExample) | ||
| JP2011524887A5 (enExample) | ||
| WO2014004436A3 (en) | Crystalline anti-human il-23 antibodies | |
| JP2013516432A5 (enExample) | ||
| JP2013236633A5 (enExample) | ||
| CN102532307A (zh) | 一种制备人免疫球蛋白的方法 | |
| RU2016151761A (ru) | Очищенные композиции белков ivig и kh для модулирования лимфоцитов и лечения вируса гепатита b | |
| HRP20200710T1 (hr) | Novi postupak za efikasno pročišćavanje humanog serumskog albumina | |
| CN102199198A (zh) | 人呼吸道合胞病毒f蛋白的纯化方法 | |
| CN102838684A (zh) | 球等鞭金藻胞外多糖的分离纯化工艺 | |
| CA2922996C (en) | Treated filter |